Diabetic foot exam EHR template that satisfies quality reporting

Quick answer

Diabetic foot exam templates

A diabetic foot exam EHR template should be built from the measure definitions rather than from clinical habit. MIPS measure 126 requires a lower extremity neurological exam consisting of a 10-gram monofilament plus any one of four named tests, and measure 127 requires a documented evaluation of footwear and sizing.

The diabetic foot exam is the rare case where the clinical standard and the quality measure are almost the same thing.

Almost. The measure is narrower and more literal than the clinical concept, and that narrowness is where practices lose credit for work they actually did.

Two measures apply, they measure different things, and the templates that satisfy them look different from the templates most practices are using.

The RealityOne mandatory test, plus any one of four

⚠️

The Problem

The exam happens; the numerator does not.

A thorough foot check documented in free text, with none of the specific elements the measure looks for.

🔧

The Solution

Build the template from the specification.

The named tests as discrete fields, the footwear evaluation as its own item, and exceptions recordable when they apply.

✅

The Resolution

Credit for the care you already deliver.

A numerator that reflects the exam, and a record that holds up when someone checks.

What the neurological evaluation measure actually requires

This is the definition that matters most, and it is more specific than “check sensation”.

The 2026 specification for measure 126, Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation, describes the percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months.

The definition of that exam is where the precision lives. The specification describes it as a documented evaluation of motor and sensory abilities that should include the 10-gram monofilament plus testing any one of the following: vibration using a 128-Hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold. It adds that the clinician should perform all necessary tests to make the proper evaluation.

So the structure is one mandatory test and any one of four alternatives. A template offering monofilament alone does not meet it. A template offering a free-text box invites the clinician to describe an exam that satisfies it without recording it in a form anyone can count.

Monofilament testing, and the site count nobody agrees on

Here we have to be careful, because this is a place where confident claims circulate without a federal source behind them.

HRSA’s LEAP monofilament instructions describe using a 10-gram monofilament to test sensation at the indicated sites on each foot, holding the filament perpendicular to the skin and using a three-step sequence of touching the skin, bending the filament and lifting it, over approximately one and a half seconds, in a random sequence. It states that loss of protective sensation at any one of the eight sites indicates a foot at high risk.

Eight sites, in HRSA’s protocol. But those eight are marked on a diagram and are never named in the text, and measure 126 specifies the monofilament without specifying a site count at all. Published protocols in the literature use three, four and ten sites. There is no single federal standard. Pick the protocol your clinicians actually follow, record which one it is, and do not let a template imply a standard that does not exist.

Key takeaway

The measure names the 10-gram monofilament. It does not name a number of sites. Any template or vendor that tells you the site count is federally standardised is telling you something that is not in the specification.

The footwear evaluation is a separate measure

Practices frequently treat footwear as part of the foot exam. For reporting purposes it is its own measure with its own numerator.

The 2026 specification for measure 127, Ulcer Prevention – Evaluation of Footwear, covers patients aged 18 and older with diabetes who were evaluated for proper footwear and sizing at least once within 12 months.

Its definition of that evaluation includes a foot examination documenting vascular, neurological, dermatological and structural or biomechanical findings, with the foot measured using a standard measuring device and counselling on appropriate footwear based on risk categorisation. The specification also allows the footwear evaluation to have been performed within the 12-month lookback rather than on the encounter date, while denominator exceptions are determined on the encounter date.

Podiatry practice staff reviewing a diabetic foot exam EHR template — The measure does not ask whether a foot exam happened. It asks whether specific tests were performed and recorded in a way a reviewer can find.

Denominator exceptions, and why they belong in the template

The measures both allow for patients where the test is not appropriate, and a template that cannot record that fact costs you performance.

Measure 126 carries a denominator exclusion for patients documented as not eligible candidates for the lower extremity neurological exam, giving examples of a bilateral amputee, a patient with a condition preventing accurate response to a neurological exam, and a patient with previously documented diabetic peripheral neuropathy with loss of protective sensation. Measure 127 excludes bilateral lower extremity amputees. Both exclude encounters conducted via telehealth.

That last one catches practices out. A telehealth visit cannot satisfy either measure, which is obvious once stated and invisible in a template that looks identical whichever way the patient was seen. This is exactly the sort of thing that surfaces during EHR workflow optimization and never surfaces in a training session.

Qventive Healthcare

Doing the exams but not getting the numerator?

We compare your templates against the current measure specifications and hand you written findings on exactly where credit is being lost.

Get Your Free Assessment (201) 488-2750

Why this matters clinically, with the current numbers

It is worth saying plainly what the measures are for, and citing the figure that is current rather than the one still sitting on an older page.

CDC’s National Diabetes Statistics Report, 2023 gives 160,000 hospital discharges for lower-extremity amputation, a rate of 6.8 per 1,000 adults with diabetes, using 2020 data. CDC’s own clinical page on promoting foot health still quotes 4.9 per 1,000 from 2016. Both are CDC; one is superseded. If you are citing this number in patient material or a referral letter, use the newer one and say which year it is.

CDC’s clinical guidance also states that annual foot exams assess pulses, sensation, foot structure and function, and nails — a broader clinical frame than either measure captures, which is the point. The measures are a floor, not a description of good care.

What the template should look like

Short list, derived from the specifications rather than from habit.

Monofilament as a discrete field. Plus the four alternatives, pickable.
Footwear evaluation as its own item. It is a separate measure.
Exceptions recordable in one click. Amputee, unable to respond, known loss of sensation.
Flag telehealth encounters. They cannot satisfy either measure.

Qventive works as a diabetic foot exam EHR template consultant for New Jersey practices, usually within broader IT support for podiatry practices rather than as an isolated build.

Template work of this kind runs through EHR template development and touches how the system is configured, which is podiatry EHR and IT support; the reporting paths involved belong in your HIPAA risk analysis like any other export.

Diabetic foot exams: common questions

What exactly counts as a lower extremity neurological exam for the measure?

The 2026 specification for measure 126 defines it as a documented evaluation of motor and sensory abilities that should include the 10-gram monofilament plus testing any one of the following: vibration using a 128-Hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold. That structure is one mandatory test plus any one of four alternatives, and it is narrower than the clinical concept of a foot exam. The specification adds that the clinician should perform all necessary tests to make the proper evaluation, so it is a floor rather than a ceiling. The practical consequence for a template is that the monofilament and the four alternatives need to be discrete, recordable items rather than prose. A clinician who performs a thorough exam and describes it in a paragraph has done the right clinical thing and produced a record that cannot be counted without someone reading it, which at scale means it does not get counted.

How many sites should the monofilament test?

There is no single federal answer, and anyone who tells you otherwise is overstating the evidence. HRSA’s LEAP protocol states that loss of protective sensation at any one of the eight sites indicates a foot at high risk, so eight is HRSA’s number. But those eight sites are shown only on a diagram in the HRSA materials and are never named in the text, and the MIPS measure specifies the 10-gram monofilament without specifying any site count. Published protocols in the literature use three, four and ten sites. The workable position is to pick the protocol your clinicians are trained in, record in the template which protocol is being used, and keep the technique consistent: HRSA describes holding the filament perpendicular to the skin, a three-step touch-bend-lift sequence over about one and a half seconds, and a random sequence so the patient cannot anticipate. Consistency of technique matters more for the clinical result than the specific count does.

Does a telehealth visit count for these measures?

No, and this is the trap that catches the most practices. Both measure 126 and measure 127 exclude encounters conducted via telehealth from the denominator. That makes obvious sense once you say it out loud, because neither a monofilament test nor a footwear measurement can be performed remotely, but it is invisible in a template that looks the same regardless of how the patient was seen. Two consequences follow. First, a practice with a high telehealth share for diabetes follow-up needs to make sure in-person visits are being used for the foot exam, not just assume it happens. Second, your template or your reporting logic needs to know how the encounter was conducted, which means the encounter type has to be reliably recorded upstream. Practices that discovered this after a reporting year had closed usually discovered it as an unexplained drop in the denominator.

What are the HIPAA implications of quality measure reporting?

Quality reporting moves patient-level clinical data out of the practice, and each route is worth documenting once rather than assuming. If a registry, a QCDR or a billing vendor prepares or transmits your submissions, is there an executed business associate agreement, and does it describe what that party actually does with the data rather than what it did when the agreement was signed. Where extracts are assembled locally before submission, where do those files sit, who can reach them, and how long are they kept, because an export directory full of patient-level clinical extracts is exactly what a risk analysis should name. Who holds accounts on the submission systems, is multi-factor authentication enforced, and is that list reviewed when someone leaves. And does the reporting tool appear in your system inventory at all. In our engagements the local extract directory is the item most often missing, because it was created by whoever set up reporting and was never treated as a system.

Are these measures worth building for if we are a small practice?

Build the template regardless of the reporting decision, because the measure definitions happen to encode a reasonable minimum standard and the documentation is useful on its own terms. A record showing which specific tests were performed and when gives the next clinician something to compare against, which a paragraph saying the foot exam was normal does not. The clinical case is real: CDC’s National Diabetes Statistics Report for 2023 reports 160,000 hospital discharges involving a lower-extremity amputation, a rate of 6.8 per 1,000 adults with diabetes, using 2020 data. Whether you report the measures is a separate question that turns on your participation status and volume, and it is worth answering deliberately rather than by default. What is not worth doing is building one template for care and a second, parallel process for reporting, because the second one always decays.

Ready when you are

Let’s meet

Qventive builds specialty templates for New Jersey practices. Thirty years healthcare-exclusive, from our office in Hackensack.

Let’s Meet (201) 488-2750

Sources

Lower extremity neurological exam: 10-g monofilament plus any one of vibration using 128-Hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold. qpp.cms.gov
Evaluation for proper footwear includes vascular, neurological, dermatological and structural or biomechanical findings; foot measured with a standard measuring device. qpp.cms.gov
Loss of protective sensation at any one of the eight sites indicates a foot at high risk; three-step touch, bend, lift technique. hrsa.gov
160,000 hospital discharges for lower-extremity amputation, 6.8 per 1,000 adults with diabetes, 2020 data. stacks.cdc.gov

Qventive Healthcare

Healthcare IT consulting and managed services, healthcare-exclusive since 1994. 200 Passaic Street, Hackensack, New Jersey. We serve as a business associate to the practices we support.

Diabetic foot exam EHR template that satisfies quality reporting

Diabetic foot exam EHR template that satisfies quality reporting

What the neurological evaluation measure actually requires

Monofilament testing, and the site count nobody agrees on

The footwear evaluation is a separate measure

Denominator exceptions, and why they belong in the template

Doing the exams but not getting the numerator?

Why this matters clinically, with the current numbers

What the template should look like

Diabetic foot exams: common questions

Let’s meet

Schedule a Consultation

Request Sent!

Something went wrong